Surprise Billing, Drug Pricing & Extenders Deferred To May 22

Updated Story Congress is creating a new opening to vote on surprise billing and drug pricing legislation next May by limiting Medicare and Medicaid extenders to five months in a year-long government funding bill. Lawmakers released a funding deal on Monday night (Dec. 16), and neither surprise billing nor drug pricing legislation are included. The so-called extenders, a package of Medicare and Medicaid policies, are included in the appropriations bill, but they’ll run for only five months...